Islet amyloid polypeptide (amylin) and insulin are differentially expressed in chronic diabetes induced by streptozotocin in rats
The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Islet amyloid polypeptide (IAPP) is overexpressed relative to insulin under several experimental conditions relevant to diabetes mellitus, including the immediate phase (7 days) following induction of streptozotocin diabetes. In the present study, IAPP and insulin gene expression were examined in chronic streptozotocin diabetes (3 weeks) in rats. Quantitative in situ hybridization, determining grain areas and optical densities of mRNA labelling, revealed that IAPP and insulin expression were reduced at the islet level at both low and high streptozotocin doses, partly due to reduced beta-cell mass. In contrast, the cellular levels of IAPP mRNA were either increased or unaffected at the low and high streptozotocin doses, respectively, whereas those of insulin mRNA were unaffected or reduced. When dexamethasone was administered to rats given the low streptozotocin dose, IAPP expression was increased, whereas that of insulin was markedly reduced. Immunocytochemistry revealed that IAPP predominantly occurred in insulin cells and to a lesser extent in somatostatin cells at all treatments examined. Our findings demonstrate that IAPP and insulin gene expression are differentially regulated; the over-expression of IAPP relative to insulin is augmented when the beta-cell insult is aggravated, in our experiments represented by massive beta-cell destruction (high streptozotocin dose) or a combination of moderate beta-cell damage and peripheral insulin resistance (low streptozotocin dose and dexamethasone). An over-expression of IAPP relative to insulin may therefore be involved in diabetes pathogenesis, contributing to its metabolic perturbations, possibly through the capacity of IAPP to restrain insulin release and action and to form islet amyloid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“What has become clear is that islet amyloid deposits are very likely to be directly involved in the pathogenesis of T2D, although it has not been well established how mechanistically.124,126,127”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [127]
Citations
Cites
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299 · cited 2×
“Furthermore, in patients with N I D D M , lAPP is the main constituent of amyloid formed in the pancreatic islets, which has been proposed to be linked to the pathogenesis of diabetes [1-3].”
BackgroundWestermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976 · cited 2×
“Furthermore, in patients with N I D D M , lAPP is the main constituent of amyloid formed in the pancreatic islets, which has been proposed to be linked to the pathogenesis of diabetes [1-3].”
Backgroundβ-cells in type II diabetes mellitus
Porte, D. (1991) · Diabetes · doi:10.2337/diab.40.2.166 · Cited by 585 · cited 1×
“Fully developed NIDDM is characterized by impaired insulin secretion in combination with reduced peripheral insulin sensitivity [8, 9].”
BackgroundYamamoto, H., Uchigata, Y., & Okamoto, H. (1981) · Nature · doi:10.1038/294284a0 · Cited by 526
The structure and evolution of the two nonallelic rat preproinsulin genes
Lomedico, P., Rosenthal, N., Efstratiadis, A., Gilbert, W., Kolodner, R., & Tizard, R. (1979) · Cell · doi:10.1016/0092-8674(79)90071-0 · Cited by 491
Leighton, B., & Cooper, G. J. S. (1988) · Nature · doi:10.1038/335632a0 · Cited by 473 · cited 2×
“One possibility is that metabolic and autocrine/paracrine effects, caused by an overexpression of IAPP relative to insulin, may restrain insulin action and release [4-7].”
BackgroundGerman, M. S., Moss, L. G., Wang, J., & Rutter, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1777 · Cited by 167
Rat amylin: cloning and tissue-specific expression in pancreatic islets.
Leffert, J. D., Newgard, C. B., Okamoto, H., Milburn, J. L., & Luskey, K. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3127 · Cited by 121
THE PANCREATIC ISLET CELLS IN INSULAR AMYLOIDOSIS IN HUMAN DIABETIC AND NON‐DIABETIC ADULTS
Westermark, P., & Grimelius, L. (1973) · Acta Pathologica Microbiologica Scandinavica Section A Pathology · doi:10.1111/j.1699-0463.1973.tb03538.x · Cited by 117 · cited 2×
“Furthermore, in patients with N I D D M , lAPP is the main constituent of amyloid formed in the pancreatic islets, which has been proposed to be linked to the pathogenesis of diabetes [1-3].”
Background
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Antioxidant and Anti‐Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus
Li, Z., Geng, Y.-N., Jiang, J.-D., & Kong, W.-J. (2014) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2014/289264 · Cited by 383
Ma, X., Chen, Z., Wang, L., Wang, G., Wang, Z., Dong, X., Wen, B., & Zhang, Z. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00782 · Cited by 188
Åhrén, B., Simonsson, E., Scheurink, A. J. W., Mulder, H., Myrsén-Axcrona, U., & Sundler, F. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90175-x · Cited by 138
Self-citationThe redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes
Camargo, D. C. R., Tripsianes, K., Buday, K., Frankó, A., Göbl, C., Hartlmüller, C., Sarkar, R., Aichler, M., Mettenleiter, G., Schulz, M., et al. (2017) · Scientific Reports · doi:10.1038/srep44041 · Cited by 105
Metadata
- Authors
- Mulder, H., Ahrén, B., & Sundler, F.
- Affiliations
- Lund University (SE)
- Corresponding author
- Mulder, H.
- ORCID
- Mulder, H.
- Venue
- Diabetologia
- Published
- 1996-06
- Volume
- 39
- Issue
- 6
- Pages
- 649-657
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1977638001
- Cited by
- 31
- References
- 35
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 2 · 2018: 2 · 2017: 1 · 2014: 2
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- amylin, insulin gene expression, streptozotocin-induced diabetes, beta-cell mass, beta cell destruction, dexamethasone, insulin resistance, somatostatin cells, islet amyloid, diabetes pathogenesis, insulin secretion
- MeSH terms
- Amyloid, Animals, Antibodies, Monoclonal, Blood Glucose, Dexamethasone, Diabetes Mellitus, Experimental, Gene Expression Regulation, Glucocorticoids, Guinea Pigs, Insulin, Islets of Langerhans, Male, Pancreas, Proinsulin, Rabbits, Radionuclide Imaging, Random Allocation, RNA, Messenger, Somatostatin, Streptozocin, Rats, Sprague-Dawley, In Situ Hybridization, Fluorescent Antibody Technique, Indirect, Rats, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.